Benzinga's Top Pre-Market Losers

Pain Therapeutics Inc. PTIE dipped 45.01% to $5.32 in the pre-market session after the company CEO revealed a letter from Pfizer PFE of reassessing its endorsement of the Remoxy program. Santarus, Inc. SNTS shares fell 6.09% to $20.20 in the pre-market trading after the company announced the launching of a Proposed Secondary Common Stock Offering by a Selling Stockholder, on Thursday. Newmont Mining Corporation NEM shares dropped 2.29% to $33.16 in pre-market trading. Newmont Mining Corporation's trailing twelve-months ROE is 5.95%. Eli Lilly and Company LLY dipped 1.04% to $54.56 in the pre-market session after the company announced its Enzastaurin Phase III Study had failed to meet Primary Endpoint in Diffuse Large B-Cell Lymphoma.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsGeneralBenzinga's Top Pre-Market Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!